Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats

Abstract The unbound concentrations of 14 commercial drugs, including five non‐efflux/uptake transporter substrates—Class I, five efflux transporter substrates—class II and four influx transporter substrates—Class III, were simultaneously measured in rat liver, muscle, and blood via microanalysis. K...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuyao Wang, Chun Chen, Chi Guan, Liping Qiu, Lei Zhang, Shaofeng Zhang, Hongyu Zhou, Hongwen Du, Chen Li, Yaqiong Wu, Hang Chang, Tao Wang
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/888cbe7245f6422fa500b10c7fc1165f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:888cbe7245f6422fa500b10c7fc1165f
record_format dspace
spelling oai:doaj.org-article:888cbe7245f6422fa500b10c7fc1165f2021-11-16T13:45:56ZEffects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats2052-170710.1002/prp2.879https://doaj.org/article/888cbe7245f6422fa500b10c7fc1165f2021-10-01T00:00:00Zhttps://doi.org/10.1002/prp2.879https://doaj.org/toc/2052-1707Abstract The unbound concentrations of 14 commercial drugs, including five non‐efflux/uptake transporter substrates—Class I, five efflux transporter substrates—class II and four influx transporter substrates—Class III, were simultaneously measured in rat liver, muscle, and blood via microanalysis. Kpuu,liver and Kpuu,muscle were calculated to evaluate the membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver. For Class I compounds, represented by antipyrine, unbound concentrations among liver, muscle and blood are symmetrically distributed when compound hepatic clearance is low. And when compound hepatic clearance is high, unbound concentrations among liver, muscle and blood are asymmetrically distributed, such as Propranolol. For Class II and III compounds, overall, the unbound concentrations among liver, muscle, and blood are asymmetrically distributed due to a combination of hepatic metabolism and efflux and/or influx transporter activity.Shuyao WangChun ChenChi GuanLiping QiuLei ZhangShaofeng ZhangHongyu ZhouHongwen DuChen LiYaqiong WuHang ChangTao WangWileyarticleasymmetrically distributedcell metabolismmembrane transportmicroanalysisunbound drug concentrationTherapeutics. PharmacologyRM1-950ENPharmacology Research & Perspectives, Vol 9, Iss 5, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic asymmetrically distributed
cell metabolism
membrane transport
microanalysis
unbound drug concentration
Therapeutics. Pharmacology
RM1-950
spellingShingle asymmetrically distributed
cell metabolism
membrane transport
microanalysis
unbound drug concentration
Therapeutics. Pharmacology
RM1-950
Shuyao Wang
Chun Chen
Chi Guan
Liping Qiu
Lei Zhang
Shaofeng Zhang
Hongyu Zhou
Hongwen Du
Chen Li
Yaqiong Wu
Hang Chang
Tao Wang
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
description Abstract The unbound concentrations of 14 commercial drugs, including five non‐efflux/uptake transporter substrates—Class I, five efflux transporter substrates—class II and four influx transporter substrates—Class III, were simultaneously measured in rat liver, muscle, and blood via microanalysis. Kpuu,liver and Kpuu,muscle were calculated to evaluate the membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver. For Class I compounds, represented by antipyrine, unbound concentrations among liver, muscle and blood are symmetrically distributed when compound hepatic clearance is low. And when compound hepatic clearance is high, unbound concentrations among liver, muscle and blood are asymmetrically distributed, such as Propranolol. For Class II and III compounds, overall, the unbound concentrations among liver, muscle, and blood are asymmetrically distributed due to a combination of hepatic metabolism and efflux and/or influx transporter activity.
format article
author Shuyao Wang
Chun Chen
Chi Guan
Liping Qiu
Lei Zhang
Shaofeng Zhang
Hongyu Zhou
Hongwen Du
Chen Li
Yaqiong Wu
Hang Chang
Tao Wang
author_facet Shuyao Wang
Chun Chen
Chi Guan
Liping Qiu
Lei Zhang
Shaofeng Zhang
Hongyu Zhou
Hongwen Du
Chen Li
Yaqiong Wu
Hang Chang
Tao Wang
author_sort Shuyao Wang
title Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
title_short Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
title_full Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
title_fullStr Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
title_full_unstemmed Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
title_sort effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: a microdialysis study in rats
publisher Wiley
publishDate 2021
url https://doaj.org/article/888cbe7245f6422fa500b10c7fc1165f
work_keys_str_mv AT shuyaowang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT chunchen effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT chiguan effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT lipingqiu effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT leizhang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT shaofengzhang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT hongyuzhou effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT hongwendu effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT chenli effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT yaqiongwu effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT hangchang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
AT taowang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats
_version_ 1718426490725466112